KIF9 Activators constitute a distinct class of chemical compounds that facilitate the activation of the molecular motor protein known as KIF9. These activators operate on a cellular level to enhance the natural functions of KIF9, which is pivotal in the intricate process of microtubule dynamics and intracellular transport. The specificity of these activators lies in their ability to bind and modify the conformational state of KIF9, thereby increasing its affinity for microtubule binding or its ATPase activity. This leads to an augmented propulsion of KIF9 along the microtubules, effectively boosting the transport of various cellular cargoes. A hallmark of these activators is their targeted action that can result in the accelerated movement of vesicles, organelles, and other macromolecular complexes to their intended destinations within the cell. By facilitating these activities, KIF9 Activators play a crucial role in maintaining cellular homeostasis and ensuring the timely delivery of essential components.
The activation mechanisms of KIF9 by these compounds are manifold, often entailing alterations to the protein's ATP-binding pocket or the microtubule-binding domain. This can lead to an increase in ATP hydrolysis rates, which is directly correlated with motor activity and velocity. Furthermore, some KIF9 Activators may indirectly enhance the protein's function by stabilizing microtubule tracks, thus providing a more robust framework for KIF9 to operate upon. Others might interact with regulatory proteins that modulate KIF9 activity, ensuring that the activators' effects are precisely tuned to the cell's requirements. The precise molecular interactions between KIF9 Activators and their targets are a testament to the sophisticated nature of cellular regulation, highlighting the intricate web of biochemical pathways that sustain life at the microscopic level. These activators exemplify the complex interplay between chemical compounds and biological macromolecules, and their study provides valuable insights into the fundamental mechanisms of intracellular transport and motility.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylyl cyclase, increasing cAMP levels within the cell. Elevated cAMP activates PKA, which can phosphorylate various proteins, potentially including KIF9, thus enhancing its motor activity and microtubule binding. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a PKC activator that phosphorylates a broad range of cellular proteins. PKC-mediated phosphorylation of proteins within the intracellular transport pathways could enhance the activity of KIF9 by increasing its cargo-binding affinity or motor function. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid inhibits protein phosphatases PP1 and PP2A, leading to increased phosphorylation levels in the cell. This could result in enhanced KIF9 function due to reduced dephosphorylation of its associated pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate is a lipid signaling molecule that can activate signaling cascades, potentially impacting KIF9 function by altering microtubule dynamics or motor protein interactions. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor; however, inhibition of PI3K can lead to altered signaling that might enhance the activity of KIF9 through feedback mechanisms that regulate microtubule-associated motor proteins. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
Vinblastine disrupts microtubule polymerization. At low concentrations, vinblastine can stimulate motor proteins like KIF9 to recognize and bind to microtubule plus ends, enhancing their activity. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Paclitaxel stabilizes microtubules and can enhance the activity of microtubule-associated proteins like KIF9 by increasing the availability of binding sites on stable microtubules. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium chloride inhibits GSK-3, which may lead to enhanced activity of microtubule-associated proteins, including KIF9, by altering their phosphorylation state. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine is a DNA methyltransferase inhibitor; while it typically modulates gene expression, it could indirectly enhance KIF9 activity by affecting the expression of proteins that regulate KIF9's function. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cAMP analog that activates PKA. PKA can then phosphorylate substrates that modulate microtubule dynamics, potentially enhancing the activity of KIF9. | ||||||